Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 15;595(24):7369-7382.
doi: 10.1113/JP274990. Epub 2017 Nov 21.

Impaired excitation-contraction coupling in muscle fibres from the dynamin2R465W mouse model of centronuclear myopathy

Affiliations

Impaired excitation-contraction coupling in muscle fibres from the dynamin2R465W mouse model of centronuclear myopathy

Candice Kutchukian et al. J Physiol. .

Abstract

Key points: Dynamin 2 is a ubiquitously expressed protein involved in membrane trafficking processes. Mutations in the gene encoding dynamin 2 are responsible for a congenital myopathy associated with centrally located nuclei in the muscle fibres. Using muscle fibres from a mouse model of the most common mutation responsible for this disease in humans, we tested whether altered Ca2+ signalling and excitation-contraction coupling contribute to muscle weakness. The plasma membrane network that carries the electrical excitation is moderately perturbed in the diseased muscle fibres. The excitation-activated Ca2+ input fluxes across both the plasma membrane and the membrane of the sarcoplasmic reticulum are defective in the diseased fibres, which probably contributes to muscle weakness in patients.

Abstract: Mutations in the gene encoding dynamin 2 (DNM2) are responsible for autosomal dominant centronuclear myopathy (AD-CNM). We studied the functional properties of Ca2+ signalling and excitation-contraction (EC) coupling in muscle fibres isolated from a knock-in (KI) mouse model of the disease, using confocal imaging and the voltage clamp technique. The transverse-tubule network organization appeared to be unaltered in the diseased fibres, although its density was reduced by ∼10% compared to that in control fibres. The density of Ca2+ current through CaV1.1 channels and the rate of voltage-activated sarcoplasmic reticulum Ca2+ release were reduced by ∼60% and 30%, respectively, in KI vs. control fibres. In addition, Ca2+ release in the KI fibres reached its peak value 10-50 ms later than in control ones. Activation of Ca2+ transients along the longitudinal axis of the fibres was more heterogeneous in the KI than in the control fibres, with the difference being exacerbated at intermediate membrane voltages. KI fibres exhibited spontaneous Ca2+ release events that were almost absent from control fibres. Overall, the results of the present study demonstrate that Ca2+ signalling and EC coupling exhibit a number of dysfunctions likely contributing to muscle weakness in DNM2-related AD-CNM.

Keywords: dynamin 2; excitation-contraction coupling; ryanodine receptor; sarcoplasmic reticulum Ca2+ release; skeletal muscle.

PubMed Disclaimer

Figures

Figure 1
Figure 1. T‐tubule network in WT and KI‐Dnm2 R465 fibres
A, x,y fluorescence images of di‐8‐anepps staining of the t‐tubule network in a WT (left) and in a KI (right) muscle fibre. The analysis shown in (B) and (C) was performed within the region of interest highlighted by a white box in each image. B, longitudinal profile of fluorescence along the corresponding region of interest shown in (A). C, outlined t‐tubule network within each region of interest; thresholding was used to create a binary image of the network. The graph in the middle shows values for the t‐tubule density index in the two groups of fibres, calculated as the percentage of above‐threshold pixels in the regions of interest.
Figure 2
Figure 2. CaV.1.1 Ca2+ current in WT and KI‐Dnm2 R465 fibres
A, representative Ca2+ current traces in a WT and in a KI fibre in response to 0.5 s long depolarizing pulses from −80 mV to the range of indicated values, by 10 mV steps. B, mean voltage‐dependence of the peak Ca2+ current in the two groups of fibres from measurements performed as shown in (A). Superimposed continuous lines show the result from fitting the mean WT and KI data points with eqn (1). C, mean values for the parameters obtained from fitting each current vs. voltage dataset with eqn (1) (see Methods). D, expression of CaV1.1 in tibialis anterior muscles: western‐blot using an antibody against the α1 subunit of the dihydropyridine receptor was performed on protein extracts from five WT and four KI mice at 5 months of age. An α‐tubulin antibody was used as loading control.
Figure 3
Figure 3. Voltage‐activated SR Ca2+ release in WT and KI‐Dnm2 R465 fibres
A, representative rhod‐2 Ca2+ transients in a WT and in a KI fibre in response to 0.5 s long depolarizing pulses from −80 mV to the range of indicated values, by 10 mV steps. B, corresponding Ca2+ release flux (d[CaTot]/dt) traces calculated as described in the Methods. C, mean voltage‐dependence of the peak rate of SR Ca2+ release in WT and KI fibres. Superimposed continuous lines show the result from fitting the mean WT and KI data points with a Boltzmann equation. The inset shows the mean values for maximal rate of SR Ca2+ release in the two groups of fibres, as assessed from Boltzmann fits to data from each fibre. D, mean values for the total amount of released Ca2+ calculated from the time integral of the Ca2+ release traces, in WT and KI fibres. E, mean values for the time to peak Ca2+ release in WT and KI fibres.
Figure 4
Figure 4. Spatial heterogeneity of time to peak SR Ca2+ release in KI‐Dnm2 R465 fibres
A, F/F 0 rhod‐2 line‐scan images taken from a WT and a KI fibre in response to a 0.5 s long depolarizing pulse from −80 to −10 mV. Traces below show the corresponding average F/F 0 signal over the full line. B, corresponding images of the rate of change in F/F 0 (dF/F 0/dt); these images were resampled from 512 to 64 pixels (0.1–0.8 μm per pixel) after linear averaging in the space domain, and the time derivative was calculated with a dt of 4 pixels (4.6 ms). Traces below show the average rate of change in F/F 0 over the full line. C, corresponding distribution of the time to peak rate of change in F/F 0 at each position along the scanned line. D, mean ± SD of the time to peak rate of change in rhod‐2 F/F 0 in WT (n = 21) and KI fibres (n = 25), in response to a pulse to −10 mV (left) and to +10 mV (right).
Figure 5
Figure 5. Examples of spatial variability of peak Ca2+ release rate in KI‐Dnm2 R465W fibres at −10 and + 10 mV
AC, images of the rate of change in rhod‐2 fluorescence (dF/F 0/dt) in three distinct KI fibres, respectively, stimulated by a voltage pulse from −80 to −10 mV (left) and by a voltage pulse from −80 to +10 mV (right). Traces underneath each image show the time course of the rate of change in F/F 0 at the three positions indicated by arrows along the line. Scale bars = 0.4 ms−1.
Figure 6
Figure 6. Ca2+ sparks in intact KI‐Dnm2 R465W fibres
A, sum of 10 x,y confocal images of fluo‐4 fluorescence from an isolated KI muscle fibre showing a localized increase in [Ca2+]. Colour bar is in arbitrary units. B, first image from the cumulated series shown in (A) after correction for baseline fluorescence (F 0) and removal of structure elements (see Methods), expressed as F/F 0. C, enlarged view of the individual spark highlighted by the square box in (B). Colour bar is the same for (B) and (C). D, Ca2+ release events amplitudes. E, FWHM of the Ca2+ release events, for profiles parallel (X) and perpendicular (Y) to the fibres axis. Arrows in (D) and (E) indicate the corresponding average values measured for the few events detected in WT fibres.
Figure 7
Figure 7. Ca2+ sparks in intact KI‐Dnm2 R465W fibres detected in line‐scan mode
A and B, normalized line‐scan images (F/F 0) of fluo‐4 fluorescence from two KI fibres showing typical calcium release events corresponding to either lone Ca2+ sparks (A) or a series of such events (B, bottom of the image) or long embers (B, marked by arrow). C, enlarged portion of the image in (A) displaying an individual event at increased temporal and spatial resolution. Traces on the right and underneath show the corresponding spatial distribution and time course of the fluorescence transient, respectively. D and E, amplitude and FWHM histograms, respectively, of the lone calcium sparks from DNM2 KI fibres.

Similar articles

Cited by

References

    1. Agrawal PB, Pierson CR, Joshi M, Liu X, Ravenscroft G, Moghadaszadeh B, Talabere T, Viola M, Swanson LC, Haliloğlu G, Talim B, Yau KS, Allcock RJ, Laing NG, Perrella MA & Beggs AH (2014). SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathy. Am J Hum Genet 95, 218–226. - PMC - PubMed
    1. Al‐Qusairi L, Weiss N, Toussaint A, Berbey C, Messaddeq N, Kretz C, Sanoudou D, Beggs AH, Allard B, Mandel JL, Laporte J, Jacquemond V & Buj‐Bello A (2009). T‐tubule disorganization and defective excitation‐contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci USA 106, 18763–18768. - PMC - PubMed
    1. Bitoun M, Maugenre S, Jeannet PY, Lacène E, Ferrer X, Laforêt P, Martin JJ, Laporte J, Lochmüller H, Beggs AH, Fardeau M, Eymard B, Romero NB & Guicheney P (2005). Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 37, 1207–1209. - PubMed
    1. Bitoun M, Bevilacqua JA, Prudhon B, Maugenre S, Taratuto AL, Monges S, Lubieniecki F, Cances C, Uro‐Coste E, Mayer M, Fardeau M, Romero NB & Guicheney P (2007). Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset. Ann Neurol 62, 666–670. - PubMed
    1. Böhm J, Biancalana V, Dechene ET, Bitoun M, Pierson CR, Schaefer E, Karasoy H, Dempsey MA, Klein F, Dondaine N, Kretz C, Haumesser N, Poirson C, Toussaint A, Greenleaf RS, Barger MA, Mahoney LJ, Kang PB, Zanoteli E, Vissing J, Witting N, Echaniz‐Laguna A, Wallgren‐Pettersson C, Dowling J, Merlini L, Oldfors A, Bomme Ousager L, Melki J, Krause A, Jern C, Oliveira AS, Petit F, Jacquette A, Chaussenot A, Mowat D, Leheup B, Cristofano M, Poza Aldea JJ, Michel F, Furby A, Llona JE, Van Coster R, Bertini E, Urtizberea JA, Drouin‐Garraud V, Béroud C, Prudhon B, Bedford M, Mathews K, Erby LA, Smith SA, Roggenbuck J, Crowe CA, Brennan Spitale A, Johal SC, Amato AA, Demmer LA, Jonas J, Darras BT, Bird TD, Laurino M, Welt SI, Trotter C, Guicheney P, Das S, Mandel JL, Beggs AH & Laporte J (2012). Mutation spectrum in the large GTPase dynamin 2, and genotype‐phenotype correlation in autosomal dominant centronuclear myopathy. Hum Mutat 33, 949–959. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources